Biotech stocks have fallen to earth with a thud in 2021 after soaring last year amid excitement over the development of COVID-19 vaccines, dealing big losses...
(Bloomberg) -- SoftBank Group Corp. extended a six-day slump with another drop of as much as 6.5% in Tokyo Monday as key companies in its portfolio delivered...
Ray Dalio, the billionaire founder of Bridgewater Associates, took to social media Sunday to "clarify" comments he made last week in which he appeared to brush...
The Competition and Markets Authority has reportedly been meeting with Microsoft's tech competitors to gauge their concerns about the Seattle company's...
Working longer can postpone cognitive decline
Read More...
It’s likely that Merck’s COVID-19 pill will be authorized in the U.S. this month but it's expected to be restricted to certain high-risk people.
Read More...
The Wall Street giant really likes these dividend stocks — for very good reasons. Read More...
Bargains aren't bargains if there's not much hope for a strong rebound move. Read More...
To give you a reference point, the Federal Reserve targets an annual inflation rate of about 2%. The question is whether it's transitory (pushed higher by...
The metaverse could be one of the biggest emerging product and service trends of 2022, but investors don't have to wait to build an early position in this...